| Product Code: ETC9945493 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 United Kingdom (UK) Gram-positive Bacterial Infections Market Overview | 
| 3.1 United Kingdom (UK) Country Macro Economic Indicators | 
| 3.2 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, 2021 & 2031F | 
| 3.3 United Kingdom (UK) Gram-positive Bacterial Infections Market - Industry Life Cycle | 
| 3.4 United Kingdom (UK) Gram-positive Bacterial Infections Market - Porter's Five Forces | 
| 3.5 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume Share, By Drug Type, 2021 & 2031F | 
| 3.6 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume Share, By Disease, 2021 & 2031F | 
| 3.7 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F | 
| 3.8 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F | 
| 4 United Kingdom (UK) Gram-positive Bacterial Infections Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of gram-positive bacterial infections in the UK | 
| 4.2.2 Growing awareness about antimicrobial resistance and the need for effective treatment options | 
| 4.2.3 Technological advancements in diagnostic tools and treatment options for gram-positive bacterial infections | 
| 4.3 Market Restraints | 
| 4.3.1 High cost associated with the development and commercialization of new antibiotics | 
| 4.3.2 Regulatory challenges and stringent approval processes for new antimicrobial drugs | 
| 5 United Kingdom (UK) Gram-positive Bacterial Infections Market Trends | 
| 6 United Kingdom (UK) Gram-positive Bacterial Infections Market, By Types | 
| 6.1 United Kingdom (UK) Gram-positive Bacterial Infections Market, By Drug Type | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Type, 2021- 2031F | 
| 6.1.3 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Antibiotic, 2021- 2031F | 
| 6.1.4 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Antifungal, 2021- 2031F | 
| 6.1.5 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.2 United Kingdom (UK) Gram-positive Bacterial Infections Market, By Disease | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By MRSA, 2021- 2031F | 
| 6.2.3 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Pneumonia, 2021- 2031F | 
| 6.2.4 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Sepsis, 2021- 2031F | 
| 6.2.5 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Sinusitis, 2021- 2031F | 
| 6.2.6 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Cellulitis, 2021- 2031F | 
| 6.2.7 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Otitis, 2021- 2031F | 
| 6.3 United Kingdom (UK) Gram-positive Bacterial Infections Market, By Route of Administration | 
| 6.3.1 Overview and Analysis | 
| 6.3.2 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Enteral, 2021- 2031F | 
| 6.3.3 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Parenteral, 2021- 2031F | 
| 6.3.4 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Others (Topical, Transdermal), 2021- 2031F | 
| 6.4 United Kingdom (UK) Gram-positive Bacterial Infections Market, By Distribution Channel | 
| 6.4.1 Overview and Analysis | 
| 6.4.2 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F | 
| 6.4.3 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F | 
| 6.4.4 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F | 
| 7 United Kingdom (UK) Gram-positive Bacterial Infections Market Import-Export Trade Statistics | 
| 7.1 United Kingdom (UK) Gram-positive Bacterial Infections Market Export to Major Countries | 
| 7.2 United Kingdom (UK) Gram-positive Bacterial Infections Market Imports from Major Countries | 
| 8 United Kingdom (UK) Gram-positive Bacterial Infections Market Key Performance Indicators | 
| 8.1 Percentage increase in investment in research and development for gram-positive bacterial infections | 
| 8.2 Number of new diagnostic tools or treatment options introduced to the market | 
| 8.3 Rate of adoption of guidelines promoting judicious use of antibiotics in the UK | 
| 9 United Kingdom (UK) Gram-positive Bacterial Infections Market - Opportunity Assessment | 
| 9.1 United Kingdom (UK) Gram-positive Bacterial Infections Market Opportunity Assessment, By Drug Type, 2021 & 2031F | 
| 9.2 United Kingdom (UK) Gram-positive Bacterial Infections Market Opportunity Assessment, By Disease, 2021 & 2031F | 
| 9.3 United Kingdom (UK) Gram-positive Bacterial Infections Market Opportunity Assessment, By Route of Administration, 2021 & 2031F | 
| 9.4 United Kingdom (UK) Gram-positive Bacterial Infections Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F | 
| 10 United Kingdom (UK) Gram-positive Bacterial Infections Market - Competitive Landscape | 
| 10.1 United Kingdom (UK) Gram-positive Bacterial Infections Market Revenue Share, By Companies, 2024 | 
| 10.2 United Kingdom (UK) Gram-positive Bacterial Infections Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |